Pharma landscape points toward need to focus on innovation: Economic Survey 2024-25
There is a need to focus on innovation, new drug development and biopharmaceuticals as spending on research and development still lags behind global leaders, said Economic Survey 2024-25 tabled in ...
Forbes India6h
Why Indian pharma needs to elevate ESG for sustainable future
Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...
Budget 2025 Expectations: Market Expert Maya Sharan Singh on Securities Transaction Tax (STT) and Industry Growth Insights!
VMPL New Delhi [India] January 31 As anticipation builds around the Union Budget 2025 investors businesses and policymakers ...
Nature13h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...